Assessment of Sleep Quality in Patients Treated for Cancer Between 15 and 24 Years of Age

NCT06904495 | Recruiting

• 1 other identifier: 25-PP-02
• Study Type: interventional
• Target: 400
• Locations: 1 country
• Sites: 1

Brief Summary

Medical professionals now take into account the specificities of the care and support of Adolescents and Young Adults (AYAs). Cancer aftermaths in patients diagnosed during the AYA period are also known: the consequences of chemotherapy and radiotherapy treatments on a growing organism, the difficulty of some follow-ups, the longevity, and the delayed occurrence of certain complications. In the general population, sleep disorders affect 40% of adolescents. About 30% of pediatric cancer survivors experience fatigue they attribute to their cancer, even years after the end of their treatment. The sleep quality of patients treated for cancer when they were AYAs, and the eventual care of sleeping disorders, are poorly studied. The investigators suppose that the oncologic treatment during this particular life stage, when sleeping disorders are already present and multifactorial, could have long-term impacts on sleep. The investigators offer to evaluate, through a questionnaire filled out by patients treated for cancer in the AYA period, the frequency of moderate to severe insomnia.

Conditions

Cancer Survivors

Outcome Measures

Primary Outcomes (1)

• Number of patients presenting moderate or severe insomnia

  Online self-administered questionnaire filled-out by the patient (120 questions) Scores between 1 and 10, yes or no, multiple choice questions, open-ended questions

  Day 1

Secondary Outcomes (1)

• Identification of sleep disorders risk factors

  Day 1

Study Arms (1)

Evaluation of sleep quality

EXPERIMENTAL

Other: Survey of sleep quality and associated factors

Interventions

Survey of sleep quality and associated factors OTHER

Sleep quality and associated factors (anxiety, depression, and pain) will be evaluated through an online survey on the Reseau Morphee platform, through an self-administered evaluation of the patients' pain and sleep difficulties, and a precarity scale.

Evaluation of sleep quality

Eligibility Criteria

• Age: 15 Years - 24 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64)

You may qualify if:

• Patient treated for a cancer
• Patient aged between 15 and 24 years old at the time of the diagnosis
• Patients whom intensive treatment ended at least 3 months ago
• Patient followed in a PACAAURA cancerology center
• Life expectancy ≥ 6 months
• Karnosky index \> 60%
• Patient who agrees to participate in the program and benefits from social security
• Patient able to understand, speak and read French.
• No major cognitive impairment (assessed by the patient's referees)
• No sensory disability

You may not qualify if:

• Patient unable to use informatic tools
• Known superior cognitive function disorders
• Progressive psychiatric pathology
• Drug user or alcohol abuse

Sponsors & Collaborators

• Centre Hospitalier Universitaire de Nice: lead

Study Sites (1)

CHU de Nice

Nice, France

RECRUITING

Central Study Contacts

Meryl Horwitz, Dr

CONTACT

492036795; horwitez.m@chu-nice.fr

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: SCREENING
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: March 21, 2025
• First Posted: April 1, 2025
• Study Start: April 15, 2025
• Primary Completion: May 5, 2026
• Study Completion: May 5, 2026
• Last Updated: February 27, 2026

Record last verified: 2026-02

Locations

FR (1)